Journey Medical (DERM) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $5.8 million.
- Journey Medical's Cost of Revenue rose 2871.84% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 930.18%. This contributed to the annual value of $20.9 million for FY2024, which is 879.74% down from last year.
- Per Journey Medical's latest filing, its Cost of Revenue stood at $5.8 million for Q3 2025, which was up 2871.84% from $4.9 million recorded in Q2 2025.
- Journey Medical's Cost of Revenue's 5-year high stood at $11.2 million during Q3 2021, with a 5-year trough of $2.2 million in Q4 2023.
- In the last 5 years, Journey Medical's Cost of Revenue had a median value of $6.4 million in 2023 and averaged $6.4 million.
- Per our database at Business Quant, Journey Medical's Cost of Revenue surged by 23048.24% in 2021 and then crashed by 7087.33% in 2023.
- Journey Medical's Cost of Revenue (Quarter) stood at $9.5 million in 2021, then decreased by 18.97% to $7.7 million in 2022, then crashed by 70.87% to $2.2 million in 2023, then skyrocketed by 108.19% to $4.7 million in 2024, then grew by 22.97% to $5.8 million in 2025.
- Its last three reported values are $5.8 million in Q3 2025, $4.9 million for Q2 2025, and $4.8 million during Q1 2025.